GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Sona Nanotech Inc (XCNQ:SONA) » Definitions » Debt-to-EBITDA

Sona Nanotech (XCNQ:SONA) Debt-to-EBITDA : -0.28 (As of Jul. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Sona Nanotech Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Sona Nanotech's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jul. 2024 was C$0.00 Mil. Sona Nanotech's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jul. 2024 was C$0.59 Mil. Sona Nanotech's annualized EBITDA for the quarter that ended in Jul. 2024 was C$-2.10 Mil. Sona Nanotech's annualized Debt-to-EBITDA for the quarter that ended in Jul. 2024 was -0.28.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Sona Nanotech's Debt-to-EBITDA or its related term are showing as below:

XCNQ:SONA' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -2.67   Med: -0.25   Max: -0.13
Current: -0.27

During the past 13 years, the highest Debt-to-EBITDA Ratio of Sona Nanotech was -0.13. The lowest was -2.67. And the median was -0.25.

XCNQ:SONA's Debt-to-EBITDA is ranked worse than
100% of 107 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.8 vs XCNQ:SONA: -0.27

Sona Nanotech Debt-to-EBITDA Historical Data

The historical data trend for Sona Nanotech's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sona Nanotech Debt-to-EBITDA Chart

Sona Nanotech Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.50 -0.24 -0.13 -0.27 -0.27

Sona Nanotech Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.27 -0.25 -0.25 -0.24 -0.28

Competitive Comparison of Sona Nanotech's Debt-to-EBITDA

For the Diagnostics & Research subindustry, Sona Nanotech's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sona Nanotech's Debt-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Sona Nanotech's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Sona Nanotech's Debt-to-EBITDA falls into.



Sona Nanotech Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Sona Nanotech's Debt-to-EBITDA for the fiscal year that ended in Oct. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 0.528) / -1.975
=-0.27

Sona Nanotech's annualized Debt-to-EBITDA for the quarter that ended in Jul. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 0.587) / -2.104
=-0.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jul. 2024) EBITDA data.


Sona Nanotech  (XCNQ:SONA) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Sona Nanotech Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Sona Nanotech's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Sona Nanotech Business Description

Traded in Other Exchanges
Address
1969 Upper Water Street, Suite 2001, Purdy’s Wharf Tower II, Halifax, NS, CAN, B3J 3R7
Sona Nanotech Inc is engaged in researching and developing gold nanorod products. It makes products for diagnostic tests and medical treatment applications. The company's product includes Gemini and Saliva tests.

Sona Nanotech Headlines

No Headlines